Get the Weekly Intelligence Brief — top committee picks every Sunday.

ARGX vs MOH

argenx SE vs Molina Healthcare, Inc. — AI-powered side-by-side comparison
ARGX
argenx SE
69
Buy
VS
MOH
Molina Healthcare, Inc.
51
Watch
MetricARGXMOH
AI Score 69 51
Price $864.40 $194.63
P/E Ratio 31.34× 1215.88×
ROE 17.6% 11.6%
Revenue Growth YoY
Gross Margin 89.9% 34.6%
Debt / Equity 0.01× 0.95×
Dividend Yield 0.0% 0.0%
RSI (14) 47.9 38.7
Beta -0.022 0.754
Expected Upside

AI Committee View

Current Innellis committee reasoning for ARGX versus MOH.
ARGX leads by 18 points.

ARGX scores 69/100 (Buy) versus MOH at 51/100 (Watch).

ARGX Committee View
67% agreement
6 analysts

The primary driver is revenue growing 71.3% yoy -- genuine top-line momentum. The main limiting factor is price-to-book of 6.9x prices in significant intangible value. The committee is constructive but not yet at full conviction.

Bull Case
  • ROE of 22.4% shows genuine earnings power backing the valuation — Value
  • Revenue growing 71.3% YoY -- genuine top-line momentum — Growth
  • EPS growing 95.7% YoY — Growth
Bear Case
  • Price-to-book of 6.9x prices in significant intangible value — Value
  • MACD histogram negative -- bearish momentum — Technical
MOH Committee View
33% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 28.5% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
  • News sentiment is positive (+0.25 across 8 articles, 14d) — News
Bear Case
  • ROE of only -0.2% -- cheap may mean cheap for a reason — Value
  • MACD histogram negative -- bearish momentum — Technical
  • Bollinger bandwidth of 28.5% signals elevated volatility — Risk
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ARGX Full Analysis MOH Full Analysis